Novel opportunities to develop VACcines to control antibiotic REsistant BActeria: from the trials back to the laboratory.
		Immunoprevention and immunotherapy of SARS infection.
		Develop and validate novel non-invasive methods for the detection of known and new biomarkers of EDs directly in the mucus of aquatic species.
		New carbohydrate-derived scaffolds for the generation of bioactive libraries.
		Type IV secretion systems as targets for anti-infectious therapies.
		Novel Strategies of Mucosal Immunisation through Exploitation of Mechanisms of Innate Immunity in Pathogen-Host Interaction. Siena, Nov. 6-10, 2002.
		Immunological memory and vaccination.
		Novel therapeutic strategies for the treatment of human autoimmune diseases.
		European research groups excellent in mucosal immunology and vaccines were here integrated into a cluster.
		Mucosal administration of antigens is a global priority and is recommended by the 5th Framework Programme of the European Union.

Legal activities

Negotations
Consortium Agreements
Intellectual Property Protection Dissemination activities

Project Web Sites
Public awareness of projects
Meetings and events

Training activities

Organization and co-ordination of training in scientific issues and
complementary skills

back